Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)

Use este identificador para citar ou linkar para este item: https://repositorio.ufms.br/handle/123456789/2145

Registro completo de metadados

Campo DC	Valor	Idioma
dc.creator	Domingos, Hamilton	-
dc.creator	Cunha, Rivaldo Venâncio da	-
dc.creator	Paniago, Anamaria Mello Miranda	-
dc.date.accessioned	2014-12-15T12:47:35Z	-
dc.date.available	2021-09-30T19:55:39Z	-
dc.date.issued	2007	-
dc.identifier.uri	https://repositorio.ufms.br/handle/123456789/2145	-
dc.description.abstract	Antiretroviral therapy has been associated with hyperlipidemia in AIDS patients. This case illustrates the classic metabolic effects associated to the HAART including protease inhibitors and/or stavudine. It was showed that the management of the HAART-associated dyslipidaemia with conventional antihyperlipidemic therapy may fail, being the switching strategy the best option.	pt_BR
dc.language.iso	eng	pt_BR
dc.publisher	Brazilian Journal of Infectious Diseases	pt_BR
dc.rights	Acesso Aberto	pt_BR
dc.title	Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)	pt_BR
dc.type	Artigo de Periódico	pt_BR
dc.identifier.doi	10.1590/S1413-86702007000200025	-
Aparece nas coleções:	CCBS - Artigos publicados em periódicos

Arquivos associados a este item:

Arquivo	Descrição	Tamanho	Formato
Dyslipidaemia associated with the highly active....pdf		27,4 kB	Adobe PDF	Visualizar/Abrir